Advertisement

Lymphatisches und retikuloendotheliales Gewebe

  • U. Göbel
  • D. Reinhardt

Zusammenfassung

Der Morbus Hodgkin (Lymphogranulomatose) scheint in T-Zell-abhängigen Arealen des lymphatischen Gewebes zu entstehen. Die eigentliche Tumorzelle ist die Reed-Sternberg-Zelle, eine Riesenzelle, deren Zuordnung nicht genau bekannt ist. Es wird vermutet, daß es sich hierbei um eine antigenpräsentierende, mononukleäre Phagozytosezelle oder Retikulumzelle handelt. Ursächlich wird ein infektiöses Agens von niedriger Virulenz oder Infektiosität als Krankheitsauslöser diskutiert. Jungen erkranken 2mal so häufig wie Mädchen. Die Erkrankung ist sehr selten vor dem 5. Lebensjahr und nimmt im Kindes- und Jugendalter bis zum 15. Lebensjahr kontinuierlich zu.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Bennett MH, MacLennan KA, Easterling MJ, Vaughan Hudson B, Vaugham Hudson G, Jelliffe AM (1985) Analysis of histological subtypes in Hodgkin’s disease in relation to prognosis and survival. In: Quaglino D, Hayhoe FGJ (eds) The cytobiology of leukaemias and lymphomas. Serono symposia publications, vol 20. Raven, New York, p 15.Google Scholar
  2. 2.
    Blayney DW, Longo DL, Young RC Greene MH, Hubbard SM, Postal MG Duffey PL, De Vita VT Jr (1987) Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin’s disease. N Engl J Med 316:710–714.PubMedCrossRefGoogle Scholar
  3. 3.
    Brämswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G (1990) The effect of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin’s disease during childhood or adolescence. Cancer 65:1298–1302.PubMedCrossRefGoogle Scholar
  4. 4.
    Donaldson SS (1991) Making choices in the staging of children with Hodgkin’s disease. Med Pediat Oncol 19:211–213.CrossRefGoogle Scholar
  5. 5.
    Garden AS, Woo SY, Fuller LM, Sullivan MP Ramirez I (1991) Results of changing treatment philosophy for children with stage I Hodgkin’s disease: a 35-year experience. Med Pediat Oncol 19:214–220.CrossRefGoogle Scholar
  6. 6.
    Meadows AT, Obringer AC, Lansberg P, Marrero O, Lemerle J (1989) Second malignant neoplasms following childhood Hodgkin’s disease: treatment and splenectomy as risk factors. Med Pediat Oncol 17: 477–484.CrossRefGoogle Scholar
  7. 7.
    Schellong G, Brämswig JH, Schwarze EW, Wannenmacher M (1988) An approach to reduce treatment. and invasive staging in childhood Hodgkin’s disease: the sequence of the German DAL multicenter studies. Bull Cancer 75:41–51.PubMedGoogle Scholar
  8. 8.
    Schellong G, Hörnig I, Brämswig JH et al. (1988) Zur Bedeutung des Procarbazins in der Chemotherapie des Morbus Hodgkin — ein Bericht der Kooperativen Therapiestudie DAL-HD-85. Klin Pädiat 200: 205–213.CrossRefGoogle Scholar
  9. 9.
    Schellong G, Lietzke S, Strauch S, Kühne B, Schneider B (1986) Bedeutung sonographischer, computertumograpischer und klinischer Befunde für die Erkennung eines Abdominalbefalls beim Morbus Hodgkin im Kindesalter — eine retrospektive statistische Analyse bei 145 Patienten der Therapiestudie DAL-HD-82. Klin Pädiat 198:147–154.CrossRefGoogle Scholar
  10. 1.
    Deeg HG, Torrisi J, Cottler-Fox M, Urban C, Gadner H, Spitzer TR (1989) Escalating doses of VP16 with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation. Bone Marrow Transplat 4 (Suppl 2):76.Google Scholar
  11. 2.
    Lennert K, Feller AC (1990) Histopathologie der Non-Hodgkin-Lymphome nach der aktualisierten Kiel-Klassifikation. Mit einem klinisch-therapeutischen Beitrag von M. Engelhard und G. Brittinger. Springer, Berlin Heidelberg New York.Google Scholar
  12. 3.
    Link MP, Donaldson SS, Berard CW, Shuster JJ, Murphy SB (1990) Results of treatment of childhood localized Non-Hodgkin’s lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 322:1169–1174.PubMedCrossRefGoogle Scholar
  13. 4.
    Müller-Weihrich S, Henze G, Jobke A et al (1982) BFM-Studie 1975/81 zur Behandlung der Non-Hodgkin-Lymphome hoher Malignität bei Kindern und Jugendlichen. Klin Pädiat 194:219–225.CrossRefGoogle Scholar
  14. 5.
    Murphy SB (1980) Classification, staging and results of treatment in childhood Non-Hodgkins lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 7:332–339.PubMedGoogle Scholar
  15. 6.
    Riehm H, Gadner J, Henze G et al (1990) Results and significance of six randomized trials in four consecutive ALL-BFM studies. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Haematology and blood transfusion, vol 33: Acute leukemias II. Springer, Berlin Heidelberg New York, pp 439–449.CrossRefGoogle Scholar
  16. 7.
    Stapleton FB, Strother DR, Roy S (1988) Acute renal failure at onset of therapy for advanced stage Burkittlymphoma and B-cell acute lymphoblastic lymphoma. Pediatrics 82:863–869.PubMedGoogle Scholar
  17. 1.
    Broadbent V, Pritchard J, Yeomans E (1989) Etoposide (VP-16) in the treatment of multisystemic Langerhans Cell Histocytosis (Histiocytosis X). Med Pediat Oncol 17:97–100.CrossRefGoogle Scholar
  18. 2.
    Broadbent V, McLelland J, Yeomans E, Pritchard J (1989) Results of conservative treatment in patients with LCH. Arch Dis Child 17:244–256.Google Scholar
  19. 3.
    Gadner H, Beck HD, Janka GE, Kühl J (1985) Histiocytosis: diagnosis and treatment. Monogr Paediat 18:1–19.Google Scholar
  20. 4.
    Gadner H, Heitger A, Ritter J et al (1987) Langerhans-Zell-Histiozytose im Kindesalter — Ergebnisse der DAI-HX 83 Studie. Klin Pädiat 199:173–182.CrossRefGoogle Scholar
  21. 5.
    Lichtenstein L (1953) Histiocytosis X: Integration of eosinophilic granuloma of bone, „Letterer-Siwe“ and „Schüller-Christian“ disease as related manifestations of a single nosologic entity. Arch Pathol 56:84–102.Google Scholar
  22. 1.
    Buckley P, Eisen R, Foucar E, Rosai J, Dorfman R (1991) Sinus histiocytosis with massive lymphadenopathy (SHML): a disease of activated macrophages? Med Pediat Oncol 19:516 (Abstr).Google Scholar
  23. 2.
    Carstensen H, Oernvold K, Georgsen J, Hansen M, Ralfkiaer E (1991) Clinicopathologic and immunologic findings in two siblings with familial hemophagocytic lymphohistiocytosis. Med Pediat Oncol 19:512 (Abstr).Google Scholar
  24. 3.
    Elinder G, Henter JI, Söder O, Üst A (1991) Isolated CNS disease; another face of familiar hemophagocytic lymphohistiocytosis (FHL). Med Pediat Oncol 19:514 (Abstr).Google Scholar
  25. 4.
    Heitger A, Bucsky P, Feller A, Riehm HJ, Gadner H (1991) Clinical similarities of large cell anaplastic lymphoma and malignant histiocytosis. Med Pediat Oncol 19:517 (Abstr).Google Scholar
  26. 5.
    Henter J, Elenden G (1991) Familial hemophagocytic lymphohistiocytosis. Acta Paediat 80:269–277.CrossRefGoogle Scholar
  27. 6.
    Komp D, Rosai J (1991) Treatment of histiocytosis with massive lymphadenopathy (SHML). Med Pediat Oncol 19:517 (Abstr).Google Scholar
  28. 7.
    Writing Group of the Histiocyte Society (1987) Histiocytosis syndromes in childhood. Lancet I:208–209.Google Scholar
  29. 1.
    Kendig EL, Brummer DL (1976) Prognosis of sarkoidosis in children. Chest 70:351.PubMedCrossRefGoogle Scholar
  30. 2.
    Pattishall EN, Strope GL, Spinola SM, Denny FW (1986) Childhood sarkoidosis. J Pediat 108:169–177.PubMedCrossRefGoogle Scholar
  31. 3.
    Wurm K (1987) Sarkoidose-Therapie, Theorie und Praxis. Med Welt 38:1649–1653.Google Scholar
  32. 4.
    Ziesche R, Matthys H (1990) Immunologische Systemerkrankungen der Lunge unbekannter Genese. Internist 31:61–68.PubMedGoogle Scholar
  33. 1.
    Eraklis AJ, Riller RM (1972) Splenektomy in childhood: a review of 1413 cases. J Pediat Surg 7:382–388.PubMedCrossRefGoogle Scholar
  34. 2.
    Likhite VV (1976) Immunological impairment and susceptibility to infection after splenectomy. JAMA 236:1376.PubMedCrossRefGoogle Scholar
  35. 3.
    Pearson HA (1980) Splenectomy, its risk and role. Hosp Pract 94:85.Google Scholar
  36. 1.
    Hilliard RI, McKendry MJ (1990) Congenital abnormalities of the lymphphatic system: A new clinical classification. Pediatrics 86:988.PubMedGoogle Scholar
  37. 1.
    Fornasiero A, Daniele O, Ghiotto C et al (1990) Chemotherapy of invasive thymoma. J Clin Oncol 8: 1419–1423.PubMedGoogle Scholar
  38. 2.
    Watts RG, Kelly DR (1990) Fatal varicella infection in a child associated with thymoma and immunodeficiency (Good’s syndrome). Med Pediat Oncol 18: 246–251.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • U. Göbel
  • D. Reinhardt

There are no affiliations available

Personalised recommendations